Introduction
One of the most striking characteristic of the brain is its profuse neuronal connectivity. Not surprisingly, the function of the nervous system critically depends on the spatiotemporal pattern of intercommunication between different regions of the brain. Both macro-and microscopic aspects of the wiring diagrams of brain circuits are relevant and need to be understood in order to cope with the complexity of the brain function. In this way, for instance, the long-range connections that carry the functional specification of cortical territories need to be studied together with the detailed microcircuits inside a cortical column. Moreover, the temporal dimension of these wiring diagrams must be investigated since neuronal networks are dynamic structures exhibiting context-dependent changes in synaptic weights ) and numbers (Chklovskii et al., 2004) . Investigations over the last decades strongly suggest that stimulus or task related neural activity is distributed over large parts of the brain, covering different cortical and sub-cortical areas. For a detailed understanding of brain function, it is of prime importance to understand the organization of the neuronal connections. To chart the anatomical connections between the various components of brain networks, the neuronal tract tracing technique has been proved to be very useful. Thus, experimental tools that allow the exploration of brain circuits at (Mishra et al., 2009) , where [Gd.DOTA] was coupled to aminopropyl-biocytin via amide bond. [Gd.L 1 ] was synthesised in seven steps prior to complexation with Gd 3+ (Scheme 2). Propylamine-biocytin 6 was synthesized in three steps, starting with the reaction of acrylonitrile on α N-carbobenzyloxy-L-lysine methyl ester giving cyano compound 4. Propinonitrile derivative 5 was obtained after coupling acid D-biotin with the secondary amine of 4 by using PyBroP as a coupling reagent and diisopropylethylamine as the base in anhydrous CH 2 Cl 2 . Subsequent selective reduction of nitrile groups in the presence of RaNi, H 2 , 7M NH 3 /MeOH yielded amine intermediate 6. The macrocycle intermediate 3 (tristert-butyl-DOTA) was obtained in two steps by stepwise alkylation of tris-tert-butyl-DO3A, 1, with benzylbromoacetate in acetonitrile generating 2, and following deprotection of benzyl groups produced the corresponding acid 3 in high yield (Pope et al., 2003) . Then, tetra-ester 7 was synthesized by coupling of amine 6 and acid 3 [EDC/HOBt/NMM] in anhydrous DMF, from which L 1 was obtained by successive deprotections (benzylcarbamate removal by hydrogenation using Pd-C as the catalyst, methyl group with LiOH and tertbutyl groups with neat TFA).
Results and discussion
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www.intechopen.com (Scheme 3) . Bromination on the hydroxyl group of N-carbobenzyloxy-L-serine methyl ester yielded 8. The bromination reaction was run for no more than 30 min. This avoided the formation of allyl analogues of the product by elimination of bromine. The most reasonable route to synthesize ligand 10 was by alkylation of 8 on 1 but the elimination of the bromine group under highly basic conditions resulted in starting compound together with allyl side product. An alternative route was taken to obtain 10 where monoalkylated intermediate 9 was generated by alkylation of excess cyclen with 8 in anhydrous toluene, which was further alkylated by tert-butylbromoacetate yielding 10. Mono-acid 11 was obtained by mild hydrolysis of the methyl ester in the presence of LiOH, which was further coupled to amine of Boc-Lys-OMe [EDC/HOBt/NMM] in anhydrous DMF to produce 12. The benzylcarbamate was hydrogenated over Pd/C to yield the secondary amine 13 which was coupled to acid D-biotin [EDC/HOBt/NMM] in anhydrous DMF to give tetra-ester 14. (Bickel et al., 2001; Cao et al., 2003; Caswell et al., 2003; Rivera et al., 2003; Weizmann et al., 2003) . Due to the high affinity of biotin to tetrameric avidin, biotinylated compounds can be visualized by light microscopy in postmortem tissues using avidin-conjugated markers. To investigate and quantify the binding behavior of the two contrast agents (CAs) to avidin which is important for the histological detection, we performed MRI experiments at 7T (300 MHz) [phosphate buffered saline (PBS), 7.4 pH, 23°C] with increasing concentrations of avidin proportional to constant concentrations of CAs (0.25 mM) and measured the proton longitudinal relaxivities (r 1p (Caravan et al., 1999) . The observed higher relaxivity in solution is explained by the high molecular volume and a significant secondsphere contribution through amide moieties close to the paramagnetic proximity present in the molecule (Aime et al., 1996; Botta, 2000) . (Table 1 ). This is in reference to the Solomon-Bloembergen-Morgan theory envisaging that at high magnetic fields, the longitudinal proton relaxivity changes with the opposite of molecular rotational correlation time (τ R ) suggesting that relaxivity change should be expected upon binding of the CAs to macromolecules (Livramento et al., 2006 
In vitro cell culture studies
It is well known from the literature that biocytin is a low molecular weight compound which has excellent uptake and transport capability in neuronal cells. Biocytin could be used as antero-as well as retrograde neuronal tract-tracer after intra-and extracellular injection in the brain (Kobbert et al., 2000) . However, the uptake mechanism of biocytin at higher concentrations is not well known. A rapid and sodium/potassium-dependent high affinity uptake of biocytin in NB2a neuroblastoma cells was reported by Baur et al. This uptake was very specific and selective to NB2a neuroblastoma cells as compared to C6 astrocytoma cells (Baur et al., 2002) . Saturation kinetic of biocytin in a low concentration range was reported. However, the biocytin concentration in the brain is well below the reported concentration at half maximal saturation (K m ) of the biocytin uptake under physiological conditions (Baur et al., 2002) . In contrast, after pressure or iontophoretic injection, local concentrations exceed the physiological concentration of biocytin manifold. Thus, the uptake mechanism under such conditions is not yet established. The Gd-chelated macrocyclic modified biocytin molecules, [Gd.L 1 ] and [Gd.L 2 ], are high molecular weight compounds as compared to biocytin alone. We investigated the cellular internalization of these compounds and their ability to enhance the MR contrast in vitro. For these studies murine N18 neuroblastoma cells were used as cellular model. In order to induce more neuronal metabolic and morphologic features in these tumor cells, serum deprivation was used to differentiate the cells (Marchisio et al., 1979) . During the slow stepwise reduction of FBS content in the culture medium to 0.625% the growth rate slowed down and cells started to show a neuronal morphology with a network of neurite-like cellular processes which were completely absent at 10% FBS. Similar in vitro studies were also performed with the FITC containing aminopropyl-biocytin [Fluo.L1]. All cell incubations were performed in HBSS/10 mM HEPES buffer for 6 hours.
In vitro studies of cellular toxicity on N18 murine neuroblastoma cells
We first tested whether the contrast agents would have an adverse effect on differentiated N18 cells. 
MRI studies on N18 murine neuroblastoma cells
] in rat brain
In the final step, we investigated the tracing abilities of these newly synthesized imaging probes, [Gd.L 1 ] and [Gd.L 2 ], by means of MRI and classical histological methods in the same experimental animal. We performed a series of pressure and iontophoretic injections into the primary motor cortex (M1) of anaesthetized albino rats (Sprague Dawley) and evaluated the transport of these compounds at 24 and 48 h post-injection (see methods section for technical details). After the local injection of [Gd.L 1 ] in the primary motor cortex of the rat, the target area was visualized in T 1 -weighted MRI as a large increase in signal (due to the decrease of the T 1 relaxation time; Figure 5A ). Statistical analysis comparing baseline images (acquired either before or immediately after the injection) with images acquired after 24 and 48 h revealed a significant increase in T 1 -weighted signal intensity in various brain regions Biocytin is a powerful tracer for visualizing connections with histological techniques. In a previous paper (Mishra et al., 2009) we have shown that both kinds of modified biocytin, aminopropyl and serine biocytin, are well suited for tracing and have, in addition, the advantage of being considerably more stable than the biocytin itself. We further investigated the post-mortem tissue sections of the same MR experimental animals. However, no stain could be seen in the case of [Gd.L 2 ], and in case of [Gd.L 1 ] the stain was restricted to places where the concentration is usually strongest, i.e. to the injection site and the striatum bundles ( Figure 6 ). This could be explained by an impaired reaction with the avidin peroxidase-DAB (3,3′-Diaminobenzidine) cocktail, necessary for histological staining. This can be concluded from the fact that our in vitro uptake studies on N18 murine neuroblastoma cells clearly revealed that these probes were taken up well by neurons even at low concentrations. The lower modulation of proton longitudinal relaxivity upon avidin binding of [Gd.L 1 ] and [Gd.L 2 ] (assuming a 2:1 stoichiometry of interaction) suggested that the interaction with avidin was strongly impaired. To further rule out the lack of uptake and/or transport and support the MRI findings, similar behavior was obtained after in vivo injections of [Fluo.L 1 ] into the primary motor cortex (M1) of anaesthetized albino rats and evaluation of the transport of this compound 24 h post-injection. We observed by fluorescence microscopy that [Fluo.L 1 ] had been taken up by neurons (Figure 7 ), but we could not detect any stain in the same section using the staining technique depending on the biotin-avidin peroxidase-DAB (3,3'-Diaminobenzidine) cocktail. It is conceivable that the modifications introduced in the model modified biocytin (aminopropyl and serine biocytin) described above, together with the significant increase in molecular weight by about a factor of 2.5, sterically hinder the staining with avidin peroxidase-DAB cocktail in cells substantially, but retain the uptake and transport properties of the resulting contrast agent. 
Conclusion
In summary, we present data on the functionalization of biocytin, a well known neuronal tract tracer, and demonstrate the validity of the approach by showing cortical connectivity in live rats with the help of MRI. Our study offers a new platform for the development of multimodal molecular imaging tools for brain connectivity studies in vivo.
Materials and methods
Chemicals
All solvents and reagents were purchased at analytical grade from commercial suppliers (Acros, Aldrich, Fluka, Merck, Strem and VWR) and were used without further purification unless otherwise stated. All air-or water-sensitive chemicals were stored under an inert atmosphere. Ultra pure de-ionised water (18 MΩ cm -1 ) was used throughout.
Chromatography
Flash column chromatography was performed using flash silica gel 60 (70-230 mesh) from Merck. Thin layer chromatography (TLC) was performed on aluminum sheet silica gel plates with 0.2 mm thick silica gel 60 F 254 (E. Merck) using different mobile phases. The compounds were visualized by UV irradiation (254 nm) or iodine staining. Reverse phase HPLC was performed at room temperature on a Varian PrepStar Instrument, equipped with PrepStar SD-1 pump heads. UV absorbance was measured using a ProStar 335 photodiode array detector at 214 nm. Analytical RP-HPLC was performed in a stainless steel Chromsep (length 250 mm, internal diameter 4.6 mm and particle size 8 µm) C 18 column and semi-preparative RP-HPLC was performed on a stainless steel Chromsep (length 250 mm, internal diameter 21.2 mm and particle size 5 µm) C 18 column (Varian). The compounds were purified using one of the following two methods. Method A: gradient with the mobile phase starting from 95% solvent A (H 2 O) and 5% of solvent B (MeOH) to 70% B in 10 min, 90% B in 18 min, 90% B isocratic till 24 min and decreased to 5% B in 28 min. Method B: 95% solvent A (H 2 O, 0.1% HCOOH) and 5% solvent B (acetonitrile, 0.1% HCOOH) to 70% solvent B in 10 min and then to 100% in the next 8 min running isocratic for 12 min and then back to 5% solvent B in the next 2 min. The flow rate generally used for analytical HPLC was 1 mL/min and for semi-preparative HPLC 15 mL/min. All the HPLC-grade solvents for HPLC were filtered through a nylon-66 Millipore filter (0.45 µm) prior to use.
Spectroscopy
1 H NMR and 13 C NMR spectra were recorded on Bruker DRX250 and DRX400 spectrometers at room temperature. The 1 H NMR chemical shifts were adjusted to the residual protons of the solvent peaks which were referenced to TMS (0.0 ppm), and 13 C NMR chemical shifts were referenced to CDCl 3 (77.0 ppm). Electrospray ionization mass spectra (ESI-MS in positive and negative ion mode) were performed on an ion trap SL 1100 system (Agilent) and High Resolution (HR) mass spectra were measured on Bruker Daltonics Apex II FT-ICR-MS (Bruker). Inductively coupled plasma optical emission spectrometry (ICP-OES) for the evaluation of the Gd 3+ concentration was performed using a Jobin-Yvon Ultima 2 spectrometer. Axial images were obtained for the set of tubes at 7T and the T 1 /T 2 values were then calculated. Relaxivity at different concentrations of avidin was then calculated using equation [1] .
In vitro MR tube measurements
where T 1,obs is the measured T 1 , T 1,d is the diamagnetic contribution of the solvent (calculated to be 2400 -2700 ms) and [GdL n ] is the concentration in mmol/L of the appropriate Gd(III) complex (n = 1-2). 1-phenyl-16-(4,7,10-tris(2-tert-butoxy-2-oxoethyl)-1,4,7 ,10-tetraazacyclododecan-1-yl)-2-oxa-4,10,14-triazahexadecane-5-carboxylate (7). A solution of compound 6 (0.3 g, 0.52 mmol), NMM (0.12 mL, 1.0 mmol) and HOBt (0.11 g, 0.57 mmol) in anhydrous DMF (15 mL) was stirred at 0-5˚C for 15 min and then EDC (0.08 g, 0.57 mmol) was added. The reaction mixture was stirred overnight at room temperature. Completion of the reaction was verified by ESI-MS, the solution was poured into water (50 mL) and extracted with EtOAc (3 x 50 mL). The combined organic layers were dried over anhydrous Na 2 SO 4 , filtered and the filtrate evaporated under reduced pressure. The residue was purified by column chromatography (silica gel, 10% MeOH in CH 2 Cl 2 , R f = 0.15) to give 7 as a yellow gum (0.28 g, 48%). .07 g) and H 2 (50 psi) in MeOH (20 mL) was stirred at room temperature in Parr-apparatus for 8 h. Completion of the reaction was verified by ESI-MS, the solution was filtered through a G-4 sintered funnel, and the filtrate was evaporated under reduced pressure. This crude product was further dissolved in TFA (20 mL) and stirred overnight at room temperature. TFA was evaporated under reduced pressure. A solution of crude product in THF:MeOH:water (3:2:2) (10 mL) was stirred at 0-5˚C for 15 min and then LiOH (0.11 g, 4.7 mmol) was added. The reaction mixture was stirred for 2 h at room temperature. Completion of the reaction was verified by ESI-MS, the solvent was evaporated under reduced pressure and the residue was purified by preparative HPLC (t R = 3.8 min). After lyophilization, L 1 was obtained as a light yellow sticky solid (0.1 g, 56% 24.9; 27.8; 28.2; 30.5; 30.9; 32.8; 35.0; 39.7; 42.4; 46.2; 47.9; 48.4; 50.7; 50.9; 51.2; 53.2; 53.8; 57.1; 58.1; 58.6; 63.0; 64.8; 164.2; 165.3; 167.2; 177.1; 178.0; 178.8 Finally N-bromosuccinimide (2.8 g, 16 mmol) was added in small aliquots to the reaction mixture. The mixture was stirred for 30 minutes at 50 °C. Heating bath was removed and 2 ml of MeOH was added to quench the reaction. 100 ml of ether was added and the reaction mixture was extracted with 100 ml water. The organic layer was dried over anhydrous Na 2 SO 4 , concentrated under vacuum and purified by column chromatography (silica gel, 30% EtOAc in n-hexane) to give 8 as a yellow gum (2.1 g, 84% Methyl 2-(benzyloxycarbonylamino)-3-(1,4,7,10-tetraazacyclododecan-1-yl) propanoate (9). Compound 8 (0.6 g, 1.9 mmol) in 25 ml of toluene was added dropwise to the solution of cyclen (2g, 11.6 mmol) in 100 ml of toluene at room temperature. The reaction mixture was refluxed for 18 h. The reaction mixture was cooled, filtered through a G-4 sintered funnel; filtrate was evaporated under reduced pressure, dissolved in 200 ml CH 2 Cl 2 , extracted from the water (4x100 ml). The organic layers were combined, dried over anhydrous Na 2 SO 4 and then concentrated under vacuum to obtain the product with cyclen. The residue was purified by column chromatography (silica gel, 10% MeOH in CH 2 Cl 2 ) to give 9 as colorless oil (0.34 g, 44% [4,7-Bis-butoxycarbonylmethyl-10-(2-(benzyloxycarbonylamino)-3-methoxy-3-oxopropyl -1,4,7,10-tetraaza-cyclododec-1-yl]-acetic acid tert-butyl ester (10). A solution of compound 9 (4.1 g, 10.1 mmol) and sodium carbonate (6.4 g, 60.0 mmol) was added in 70 ml MeCN (dry) and heated at 60 °C for 1 h. The reaction mixture was cooled and tert-butylbromoacetate (5.29 ml, 27.1 mmol) in MeCN (25 ml) was added dropwise. The mixture was then refluxed for 6 h. It was then filtered through a G-4 sintered funnel, washed with MeCN and concentrated under vacuum. The obtained residue was taken in CH 2 Cl 2 (100 ml) and extracted with water (2x50 ml). The organic layer was dried over anhydrous Na 2 SO 4 and concentrated to yellow oil. The residue was purified by column chromatography (silica gel, 5% MeOH in CH 2 Cl 2 ) to give 10 as light yellow solid (3.5 g, 72%). 1 H NMR (CDCl 3 , 250 MHz), δ (ppm): 1.32 (s, 9H); 1.39 (s, 18H); 1.83-2.56 (m, 8H); 2.60-3.50 (m, 16H); 3.66 (s, 3H); 4.47 (br s, 1H); 4.71 (br s, 1H); 5.24 (s, 2H); 7.16-7.42 (m, 5H). 13 C NMR (CDCl 3 , 62.9 MHz), δ (ppm): 27.8; 28.0; 50.3; 50.5; 51.3; 52.3; 52.6; 53.3; 55.5; 56.1; 56.5; 66.9; 82.1; 82.4; 127.7; 127.9; 128.3; 135.9; 157.0; 171.8; 172.7; 173 2-(benzyloxycarbonylamino)-3-(4,7,10-tris(2-tert-butoxy-2-oxoethyl)-1,4,7 ,10-tetraazacyclododecan-1-yl)propanoic acid (11). A solution of compound 10 (0.1 g, 0.13 mmol) was stirred in 7 mL of THF:MeOH:water (3:2:2) at 0-5˚C for 15 min and then LiOH (6.5 mg, 0.27 mmol) was added. The reaction mixture was stirred for 2 h at room temperature. The progress of the reaction was checked by ESI-MS. After completion, the reaction mixture was concentrated under reduced pressure and 11 was obtained as white powder (0.76 g, 64%). 1 H NMR (CDCl 3 , 250 MHz), δ (ppm): 1.32 (s, 9H); 1.39 (s, 18H); 1.83-2.56 (m, 8H); 2.60-3.50 (m, 16H); 4.47 (br s, 1H); 4.71 (br s, 1H); 5.24 (s, 2H); 7.16-7.42 (m, 5H). 13 C NMR (CDCl 3 , 62.9 MHz), δ (ppm): 27.8; 28.0; 50.3; 50.5; 52.3; 52.6; 53.3; 55.5; 56.1; 56.5; 66.9; 82.1; 82.4; 127.7; 127.9; 128.3; 135.9; 157.0; 171.8; 172.7 [4,7-Bis-butoxycarbonylmethyl-10-(2-(benzyloxycarbonylamino)-3-((R)-5-(tertbutoxycarbonylamino)-6-methoxy-6-oxohexylamino)-3-oxopropyl-1,4,7,10-tetraazacyclododec-1-yl]-acetic acid tert-butyl ester (12). Compound 11 (0.29 g, 0.4 mmol) was dissolved in DMF (5 ml, dry) and NMM (0.1 ml, 0.9 mmol), EDC (0.086 g, 0.44 mmol) and (R)-methyl 6-amino-2-(tert-butoxycarbonylamino)hexanoate (0.16 mmol, 0.6 mmol) were added under N 2 atmosphere. The reaction mixture was stirred at 60°C for 1h. Thereafter, HOBt (0.06 g, 0.44 mmol) was added and the heating was continued for 3 h. DMF was evaporated under reduced pressure and the obtained residue was dissolved in EtOAc. The organic layer was washed with water, dried under anhydrous Na 2 SO 4 , and concentrated under reduced pressure to obtain crude yellowish residue. This was purified by column chromatography (silica gel, 5% MeOH in CH 2 Cl 2 ) to obtain 12 as yellowish solid (46%, 0. 22.7, 27.8, 27.9, 28.0, 28.2, 28.8, 31.9, 38.8, 49.9, 52.0, 53.3, 53.5, 55.4, 56.3, 56.4, 66.1, 79.4, 81.8, 81.9, 82.3, 127.3, 127.4, 128.1, 136.8, 155.4, 157.0, 171.8, 172.0, 173.3 22.7, 27.9, 28.1, 28.3, 28.8, 32.0, 39.3, 49.9, 51.2, 52.2, 53.5, 55.4, 56.8, 57.8, 79.6, 81.6, 81.9, 82.5, 155.5, 167.67, 167.75, 170.7, 173.4 Compound 13 (0.045 g, 0.053 mmol) was dissolved in anhydrous DMF (2 ml) and HATU (0.022 g, 0.058 mmol) and DIPEA (0.019 ml, 0.1 mmol) were added under inert atmosphere. The reaction mixture was stirred at room temperature for 18 h. The formation of 14 was confirmed by ESI-MS, the solvent was evaporated under reduced pressure and the residue was redissolved in ethylacetate and washed with water. The collected organic layer was dried with anhydrous Na 2 SO 4 and evaporated under reduced pressure till dry. The residue was subjected to global deprotection. Methyl ester hydrolysis was carried out by LiOH (0.13 mmol, 0.005 g) in THF:MeOH:H 2 O (3:3:2) for 2h. The solvent was evaporated and the residue dissolved in TFA (10 ml, neat) to hydrolyze tert-Bu-ester and deprotect the Boc group. TFA was evaporated under reduced pressure to obtain a yellowish residue. The residue was redissolved in water, the pH was increased to 7 and thereafter purified by RP-HPLC (t R = 4.8) to obtain the product, L 2 , as a yellow sticky solid. 1 H NMR (300 MHz, D 2 O), δ (ppm): 1.33 (br. s., 4 H), 5 H), (dd, J=7.88, 4.58 Hz, 1 H), 4.53 (dd, J=7.63, 5. 20.8, 20.9, 23.9, 24.0, 26.9, 27.2, 27.3, 29.0, 34.0, 38.1, 38.9, 46.8, 48.5, 49.9, 51.5, 52.4, 52.8, 53.2, 54.58, 54.68, 55.1, 55.8, 59.4, 61.2, 149.9, 164.5, 173.0, 176.8 and L 2 were prepared from corresponding solutions of the ligands (1 eq) and solutions of GdCl 3 .6H 2 O (1.1 eq). The reaction mixture was stirred at 60°C for 20 h. The pH was periodically checked and adjusted to 6.5 using solutions of NaOH (1 M) and HCl (1 N) as needed. After completion, the reaction mixture was cooled and passed through chelex-100 to trap free Gd 3+ ions, and the Gd-loaded complexes were eluted. The absence of free Gd 3+ was checked with xylenol orange indicator. The fractions were lyophilized to obtain offwhite solids. These complexes were characterized by ESI-MS in positive and negative mode and the appropriate isotope pattern distributions for Gd 3+ in HBSS/10mM HEPES for 6h. After incubation samples of the treatment solution were collected, if required centrifuged, and 500 µl were used for determination of R 1 and R 2 . Cells were repeatedly washed with HBSS, trypsinized, centrifuged and re-suspended in 0.5 ml Eppendorf tubes at a cell density of 1 x 10 7 /500µl in complete medium. Cells were allowed to settle before MR measurements. Tubes with medium only and cells without CA were used as controls. Two tubes of treatment solutions, HBSS/10 mM HEPES as well as of cells for each condition were used. Experiments were done at least twice. MR imaging of the cell pellets at room temperature (~21 ˚C) was performed in a 3 T (123 MHz) human MR scanner (MAGNETOM Tim Trio, Siemens Healthcare, Germany), using a 12-channel RF Head coil and slice selective measurements from a slice with a thickness of 1 mm positioned through the cell pellet. T 1 was measured using an inversion-recovery sequence, with an adiabatic inversion pulse followed by a turbo-spin-echo readout. Between 10 and 15 images were taken, with the time between inversion and readout varying from 23 ms to 3000 ms. With a repetition time of 10 s, 15 echoes were acquired per scan and averaged six times. For T 2 , a homewritten spinecho sequence was used with echo times varying from 18 ms to 1000 ms in about 10 steps and a repetition time of 8 s. Diffusion sensitivity was reduced by minimizing the crusher gradients surrounding the refocusing pulse. All experiments scanned 256 2 voxels in a fieldof-view of 110 mm in both directions resulting in a voxel volume of 0.43 × 0.43 × 1 mm 3 . Data analysis was performed by fitting to relaxation curves with self-written routines under MATLAB 7.1 R14 (The Mathworks Inc., United States). The series of T 1 relaxation data were fitted to the following equation. T 1 series with varying t = T I : S = S 0 (1 -exp(-t / T 1 ) + S (TI = 0) exp(-t / T 1 ). Nonlinear least-squares fitting of three parameters S 0 , S (TI = 0) , and T 1 was done for manually selected regions-of-interest with the Trust-Region Reflective Newton algorithm implemented in MATLAB. The quality of the fit was controlled by visual inspection and by calculating the mean errors and residuals. Evaluation of the signal intensities in the T 1 -weighted MR images were performed in ImageJ (http://rsb.info.nih.gov/ij) by defining a circular region of interest (ROI) inside one tube image and measuring the mean signal intensity and standard deviation in the included voxels. Further statistical analyses were performed in GraphPad Prism 5.03 (GraphPad Software, Inc., USA). 
Synthesis of ligands and tracers (S)-methyl 3,15-dioxo-10-(5-((3aR,4R,6aS)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-
In vivo rat experiments
Injections
All rats were anaesthetized with 2% isoflurane (Abbott) and placed in a stereotaxic frame (Kopf Instruments). After additional use of xylocain for local analgesia in the surgery area, a craniotomy was performed and a pulled fused silica capillary (ID 50µm; OD 150 µm; tip diameter 20-30 µm) was placed in the primary motor cortex at a depth of 1.2 mm below the surface. One compound per animal was then injected using a pressure cell containing the compound attached to the other end of the fused silica capillary. 100 nl of 4% tracer solution was injected at a flow rate of 3.3 nl/min. After injection, the capillary was left in place for 10 minutes before retracting it stepwise to avoid backflow of the injected solution. In some cases we made iontophoretic injections, using borosilicate pipettes with tip diameters of 20-25 µm. In case of the injection shown in Fig. 6 , injection time was 35 min (7s on, 7 s off) with a current of 4 µA. In case of the injection shown in Fig. 7 , injection time was 70 min (7 s on, 7 s off) with a current of 10 µA. At the end of the procedure, the animals received an intraperitoneal injection of analgesics and antibiotics [5mg/kg Baytril® (Bayer) and 2.5mg/kg Finadyne® (Essex)]. The animals to be left for 48 h received another injection of analgesics and antibiotics after 24 h.
In vivo MRI experiments
For the MRI experiments, the animals were anaesthetized with 1.5-2% isoflurane and placed in a home-made quadrature coil integrated within a stereotaxic animal holder. The head holder was adapted with movable bite and ear bars and positioned fixed on a magnet chair. This allowed precise positioning of the animal with respect to the coil and the magnet, avoiding movement artifacts. Body temperature, heart rate, CO 2 and SpO 2 were monitored throughout the scanning session. We typically scanned the animals before, immediately after and 24-48 h after the injection of CAs. One scan session consisted on 5 to 7 scans of 18 min each. Experiments were carried out in a vertical 7T (300 MHz)/60-cm diameter bore magnet (Bruker BioSpin, Ettlingen). The saddle coil, which was designed to generate a homogeneous field over the whole rat brain, was used to transmit and receive. The MR system was controlled by a Bruker BioSpec console (ParaVision 3, 4 and 5 at different time periods) running under Linux operating system. We used a Modified Driven Equilibrium Fourier Transform (MDEFT) method with MDEFT-preparation (Lee et al., 1995) to obtain T 1 -weighted anatomical images. The scan parameters were: TR = 22.2 ms, TE = 4.8 ms, FA = 20°, ID = 1000 ms and four segments. The geometric parameters of the 3D scans were: matrix 192×136×100, FOV = 48×34×25 mm and voxel size 0.25×0.25×0.25 mm. The MRI images were analyzed with custom-developed Matlab functions (v7.5.0, MathWorks). An automated realignment procedure of SPM (statistical parametric mapping, www.fil.ion.ucl.ac.uk) was applied to co-register all scans. For statistical analysis the image intensity was normalized to reference signal intensity in the head muscles. Statistical maps were generated by implementing a Student's t-test (unpaired) at each voxel comparing brain images before and 24-48h after CAs injection. The significant voxels represent the pattern of T 1 -weighted MRI signal enhancement induced by the neuronal transport of CAs. The
